marginally significantP = 0.05
Similar findings were seen for RFS although the interaction was marginally significant ( P = 0.05) and the benefit of intensive chemotherapy in patients with non-t-AML was less pronounced (Fig. 3b ).
Similar findings were seen for RFS although the interaction was marginally significant ( P = 0.05) and the benefit of intensive chemotherapy in patients with non-t-AML was less pronounced (Fig. 3b ).